The adrenal glands, small yet potent, play a pivotal role in maintaining the body's homeostasis. However, these glands are susceptible to a variety of disorders that can disrupt their normal function, leading to a wide range of clinical manifestations. Understanding these disorders is crucial for healthcare professionals.
Adrenal insufficiency, a condition characterized by inadequate cortisol production, can be classified as primary or secondary. Primary adrenal insufficiency, also known as Addison's disease, is often caused by autoimmune destruction of the adrenal cortex. Secondary adrenal insufficiency, on the other hand, is typically a result of pituitary diseases or prolonged glucocorticoid therapy. Clinical presentations vary but may include fatigue, weight loss, and hyperpigmentation.
Adrenal hyperfunction, such as Cushing's syndrome, is characterized by excessive cortisol production. It can be caused by adrenal adenomas, pituitary adenomas (Cushing's disease), or ectopic ACTH production. Its clinical manifestations may include central obesity, hypertension, and glucose intolerance. Hyperaldosteronism, another form of adrenal hyperfunction, leads to hypertension and hypokalemia.
Adrenal incidentalomas, incidental adrenal masses, are increasingly identified due to widespread use of imaging studies. Though most are nonfunctioning adenomas, some may secrete excess hormones or represent malignancies, necessitating careful evaluation.
Genetic disorders such as congenital adrenal hyperplasia (CAH) can also impact adrenal function. CAH, caused by enzymatic defects in cortisol synthesis, can lead to virilization and salt-wasting crises.
Adrenal disorders, while diverse, share a common thread: disruption of normal adrenal function with significant clinical implications. A thorough understanding of these conditions is essential for healthcare professionals to ensure prompt diagnosis and appropriate management. By unraveling the complexity of adrenal disorders, we can better serve our patients and improve their quality of life.
1.
Year in Review: Non-Small Cell Lung Cancer
2.
Study suggests around 40% of postmenopausal hormone positive breast cancers are linked to excess body fat
3.
The need for more Latinx participants in Alzheimer's trials is urgent.
4.
Why palliative care goes hand in hand with treatment for people with cancer: Q&A
5.
MRD-Guided Azacitidine May Delay Relapse in AML, MDS
1.
Exploring the Benefits of Teclistamab for Treating Advanced Cancer
2.
The Danger of Methemoglobinemia and How to Prevent It
3.
Deciphering FFR: A Comprehensive Guide to Understanding Its Meaning
4.
Red Blood Cell Microparticles: Tiny Warriors Against Bleeding in the Brain
5.
Artificial Intelligence in Oncology: Current Trends, Challenges and Future Outlook
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Daratumumab, Lenalidomide, and Dexamethasone (DRd) Versus Lenalidomide and Dexamethasone (Rd) in MRD Negativity
2.
Lorlatinib in the Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)
3.
Thromboprophylaxis In Medical Settings
4.
Post Progression Approaches After First-line Third-Generaion ALK Inhibitors
5.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part VII
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation